DeepMind spinout Isomorphic Labs seeks funding at $40B–$50B valuation
Source Summary
Isomorphic Labs, a spinout from Google's DeepMind, is in talks to raise funding at a valuation between $40 billion and $50 billion, according to reports. The company applies AI to drug discovery and development.
Why it matters
The valuation reflects investor confidence in AI-driven drug discovery as a high-value commercial application and signals continued capital flow into AI-focused biotech ventures.
What remains uncertain
The funding round has not been finalized; the actual valuation and amount raised remain subject to negotiation.
